| 709 |
FSbC2 (2025) |
7. Country report of Japan
|
Michiho ITO |
Japan |
| 708 |
FSbC2 (2025) |
14 FHH SC2 2025 Time table (PW111111)
|
Young Woo, Kim (Chairperson of Subcommittee 2) |
Republic of Korea |
| 707 |
FSbC2 (2025) |
13 Hepatoprotective Effect of Korean Red Ginseng Extract
|
Sung-Hwan KI (Chosun University, Korea) |
Republic of Korea |
| 706 |
FSbC2 (2025) |
12 Development of an efficient and reliable DNA-based authentication system for Korean ginseng (Panax ginseng)
|
Jiho SEO (KGC, Korea) |
Republic of Korea |
| 705 |
FSbC2 (2025) |
11. HPTLC and Its Position in International Regulations
|
Tien DO (HPTLC Assoc., Switzerland) |
HPTLC Assoc., Switzerland |
| 704 |
FSbC2 (2025) |
10. Recent Developments of Botanical Standards
|
Nam-Cheol KIM (USP, USA) |
Republic of Korea |
| 703 |
FSbC2 (2025) |
9 Insights into the differentiation of Ginseng species (Panax ginseng, P. quinquefolius, P. notoginseng, P. vietnamensis Ha et Grushv.) by chromatographic techniques
|
HA Minh Hien (Vietnam) |
Vietnam |
| 702 |
FSbC2 (2025) |
8. Regulatory Control of Chinese Medicine in Hong Kong
|
Kelvin Chun-wai TSE (Hong Kong) |
Hong Kong |
| 701 |
FSbC2 (2025) |
6. Quality control of Storax
|
Xiaohuan GUO (NIFDC, China) |
China |
